Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Astellas Pharma Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Astellas Pharma Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Astellas Pharma Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Astellas Pharma Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
| Astellas Pharma Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
| Astellas Pharma Inc., Medical Equipment, Deal Details | 11 | 16 |
| Partnerships | 11 | 1 |
| International Stem Cell Enters Into An Agreement With Advanced Cell Technology | 11 | 1 |
| Medivation and NanoString Technologies Enter into Partnership With Astellas Pharma | 12 | 2 |
| Qiagen Enters into Co-Development Agreement with Astellas Pharma | 14 | 1 |
| Astellas Pharma Enters Into Co-Marketing Agreement With Nippon Kayaku For A670 | 15 | 1 |
| Zogenix Terminates Co-Promotion Agreement With Astellas Pharma US For Sumavel DosePro | 16 | 1 |
| Equity Offering | 17 | 1 |
| Advanced Cell to Raise USD30 Million in Private Placement of Shares | 17 | 1 |
| Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For US$35 Million | 18 | 1 |
| Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For US$1 Million | 19 | 1 |
| Advanced Cell Technology Completes Private Placement Of US$4 Million | 20 | 2 |
| Advanced Cell Technology Completes First Tranche Private Placement Of US$1.5 Million | 22 | 2 |
| Acquisition | 24 | 1 |
| Daiichi Sankyo Completes Acquisition Of Plexxikon | 24 | 3 |
| Astellas Pharma Inc. - Key Competitors | 27 | 1 |
| Key Employees | 28 | 4 |
| Locations And Subsidiaries | 32 | 7 |
| Head Office | 32 | 1 |
| Other Locations &Subsidiaries | 32 | 7 |
| Recent Developments | 39 | 1 |
| Financial Announcements | 39 | 1 |
| Jul 29, 2016: Astellas Reports First Quarter Financial Results of FY2016 | 39 | 2 |
| Corporate Communications | 41 | 1 |
| Jul 18, 2016: Astellas Promotes John Demaree to Vice President of Oncology Marketing in the Americas Region | 41 | 1 |
| Jul 06, 2016: Astellas Named to FTSE4Good Sustainability Index for the Fifth Consecutive Year | 42 | 1 |
| Apr 27, 2016: Astellas Announces Changes to Representative Director and Audit &Supervisory Board Member | 43 | 1 |
| Apr 25, 2016: Astellas Announces Key Leadership Appointments in Ethics and Compliance and US Legal Organizations | 44 | 1 |
| Mar 04, 2016: Astellas Announces Leadership Changes | 45 | 1 |
| Feb 08, 2016: Astellas Names James Robinson President, Americas Operations | 46 | 1 |
| Oct 27, 2015: Astellas Promotes Doug Geiger to Vice President, Head of New Therapeutic Areas in Marketing Strategy | 47 | 1 |
| Sep 15, 2015: Jamie McGarvey joins Astellas Pharma Corporate Affairs Team | 48 | 1 |
| Aug 20, 2015: Astellas Announces Changes in Personnel and Sales and Marketing Structure in Japan | 49 | 1 |
| Other Significant Developments | 50 | 1 |
| Aug 08, 2016: Proteostasis Therapeutics Achieves Preclinical Milestone in Astellas Pharma Collaboration | 50 | 1 |
| Apr 01, 2016: Establishment and Start of Operations of Malaysia Subsidiary and Umbrella Organization Covering South East and South Asia Regions | 51 | 1 |
| Appendix | 52 | 1 |
| Methodology | 52 | 1 |
| About GlobalData | 52 | 1 |
| Contact Us | 52 | 1 |
| Disclaimer | 52 | 1 |